311 related articles for article (PubMed ID: 23876151)
21. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
[TBL] [Abstract][Full Text] [Related]
22. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
23. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
[TBL] [Abstract][Full Text] [Related]
24. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.
Byrne JA; Strautnieks SS; Ihrke G; Pagani F; Knisely AS; Linton KJ; Mieli-Vergani G; Thompson RJ
Hepatology; 2009 Feb; 49(2):553-67. PubMed ID: 19101985
[TBL] [Abstract][Full Text] [Related]
25. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
Mareux E; Lapalus M; Amzal R; Almes M; Aït-Slimane T; Delaunay JL; Adnot P; Collado-Hilly M; Davit-Spraul A; Falguières T; Callebaut I; Gonzales E; Jacquemin E
Liver Int; 2020 Aug; 40(8):1917-1925. PubMed ID: 32433800
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.
Telbisz Á; Homolya L
Expert Opin Ther Targets; 2016; 20(4):501-14. PubMed ID: 26573700
[TBL] [Abstract][Full Text] [Related]
27. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
[TBL] [Abstract][Full Text] [Related]
28. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.
Chen HL; Chen HL; Yuan RH; Wu SH; Chen YH; Chien CS; Chou SP; Wang R; Ling V; Chang MH
J Cell Mol Med; 2012 Nov; 16(11):2679-89. PubMed ID: 22564513
[TBL] [Abstract][Full Text] [Related]
30. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
31. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
32. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
[TBL] [Abstract][Full Text] [Related]
33. [Childhood cholestasis and bile transporters].
Hierro L; Jara P
Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
[TBL] [Abstract][Full Text] [Related]
34. The canalicular bile salt export pump BSEP (ABCB11) as a potential therapeutic target.
Stieger B; Beuers U
Curr Drug Targets; 2011 May; 12(5):661-70. PubMed ID: 21039337
[TBL] [Abstract][Full Text] [Related]
35. BSEP: function and role in progressive familial intrahepatic cholestasis.
Thompson R; Strautnieks S
Semin Liver Dis; 2001 Nov; 21(4):545-50. PubMed ID: 11745042
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.
Liu T; Wang RX; Han J; Hao CZ; Qiu YL; Yan YY; Li LT; Wang NL; Gong JY; Lu Y; Zhang MH; Xie XB; Yang JC; You YJ; Li JQ; Knisely AS; Borchers CH; Ling V; Wang JS
Liver Int; 2018 Sep; 38(9):1676-1685. PubMed ID: 29412511
[TBL] [Abstract][Full Text] [Related]
37. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
39. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
[TBL] [Abstract][Full Text] [Related]
40. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
